| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  Ancitabine | Ancitabine | Potency | 0.094 | uM | ALA2114780 | inconclusive | nM | Homo sapiens | |||
| 2. | Ancitabine | Ancitabine | Potency | 0.106 | uM | ALA2114843 | inconclusive | nM | Homo sapiens | |||
| 3. | Ancitabine | Ancitabine | Potency | 0.188 | uM | ALA2354254 | active | nM | Homo sapiens | |||
| 4. | Ancitabine | Ancitabine | Potency | 0.168 | uM | ALA2354221 | active | nM | Homo sapiens | |||
| 5. | Ancitabine | Ancitabine | inhibition | = | -0.21 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 6. | Ancitabine | Ancitabine | inhibition | = | -0.04 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 7. | Ancitabine | Ancitabine | Inhibition | = | 5.17 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 8. | Ancitabine | Ancitabine | Inhibition | = | 19.76 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 9. | Ancitabine | Ancitabine | pIC50 | < | 4.7 | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | |||
| 10. | Ancitabine | Ancitabine | IC50 | > | 0 | M | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | ||
| 11. | Ancitabine | Ancitabine | inhibition | = | -0.21 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 12. | Ancitabine | Ancitabine | inhibition | = | -0.04 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 13. | Ancitabine | Ancitabine | inhibition | = | -1.34 | % | ALA4808150 | % | Homo sapiens | |||
| 14. | Ancitabine | Ancitabine | inhibition | = | 0.08 | % | ALA4808149 | % | Homo sapiens | |||
| 15. | Ancitabine | Ancitabine | Inhibition | = | -3.17 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 16. | Ancitabine | Ancitabine | AC50 | > | 30 | uM | ALA5291731 | Summarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">") | nM | Homo sapiens | ||
| 17. | Ancitabine | Ancitabine | AC50 | > | 30 | uM | ALA5291887 | Summarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">") | nM | Homo sapiens | ||
| 18. | Ancitabine | Ancitabine | AC50 | > | 30 | uM | ALA5291761 | Summarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">") | nM | Homo sapiens | ||
| 19. | Ancitabine | Ancitabine | AC50 | > | 30 | uM | ALA5291759 | Summarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">") | nM | Homo sapiens | ||
| 20. | Ancitabine | Ancitabine | AC50 | > | 30 | uM | ALA5291730 | Summarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">") | nM | Homo sapiens |
The page will load shortly, Thanks for your patience!